About
Fit4D's primary market is diabetes Pharma for which adherence to the drug or device Rx is a $20 billion/year problem. For pharmaceutical companies with a branded diabetes drug or device, Fit4D is a platform that improves adherence to the drug or device unlike reminder apps or call centers. Fit4D optimizes the mix between technology and human touch points, by enabling expert diabetes clinicians (CDEs) to improve adherence in an affordable and scalable manner. By empowering every CDE with a data-driven approach to medication adherence, we increase each CDE’s patient capacity by 2.3x (from 120 to 400!) The platform provides electronic interactions in patient-preferred modalities (e.g. phone, email, text, web, etc.) that address patient-specific issues (e.g. one patient overwhelmed, other is scared of needles, etc), in the patient’s preferred format (e.g. articles, videos, webinars, etc). Secondary and growth markets for Fit4D are payers and non-diabetes Pharma.